First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study

Por van Meerten, E, Eskens, F A L M, van Gameren, E C, Doorn, L, van der Gaast, A
Publicado em 2007

Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area

Por Alberda, W. J., Haberkorn, B. C., Morshuis, W. G., Oudendijk, J. F., Nuyttens, J. J., Burger, J. W. A., Verhoef, C., van Meerten, E.
Publicado no Int J Colorectal Dis (2015)

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

Por van Meerten, E, Muller, K, Tilanus, H W, Siersema, P D, Eijkenboom, W M H, van Dekken, H, Tran, T C K, van der Gaast, A
Publicado em 2006

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.

Por Schellens, J. H., Ma, J., Planting, A. S., van der Burg, M. E., van Meerten, E., de Boer-Dennert, M., Schmitz, P. I., Stoter, G., Verweij, J.
Publicado em 1996

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

Por Kwakman, Johannes J. M., Vink, G., Vestjens, J. H., Beerepoot, L. V., de Groot, J. W., Jansen, R. L., Opdam, F. L., Boot, H., Creemers, G. J., van Rooijen, J. M., Los, M., Vulink, A. J. E., Schut, H., van Meerten, E., Baars, A., Hamberg, P., Kapiteijn, E., Sommeijer, D. W., Punt, C. J. A., Koopman, M.
Publicado no Int J Clin Oncol (2017)